Parallel gene delivery from spinal cord bridges
Parallel gene delivery from spinal cord bridges
批准号:
7416586
负责人:
Lonnie D Shea
金额:
$17.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-01 至 2011-04-30
关键词:
AffectAntigen-Presenting CellsArchitectureBiocompatible MaterialsCell DeathCell TransplantationCell TransplantsCellsCombined Modality TherapyComplexDNADNA deliveryDemyelinationsDevelopmentEnd PointGene DeliveryGene TransferGlycolic-Lactic Acid PolyesterGoalsIn VitroIndividualInjuryLengthLocalizedLocationMediatingModelingMotorNatural regenerationNeuritesNeuronsNumbersOligodendrogliaParalysedPlasmidsPopulationPumpSensorySignal TransductionSiteSpatial DistributionSpinal CordSpinal Cord TractTestingTissue EngineeringTissuesTransfectionaxon growthbasedesignimplantationin vivoneural tractneurotrophic factorspinal cord regenerationtransgene expression
中文摘要
描述(由申请人提供):脊髓损伤导致损伤水平以下的瘫痪,其原因是神经元和少突胶质细胞死亡,轴突丧失,脱髓鞘,以及脊髓神经元再生能力有限。尽管脊髓神经元具有先天的再生能力,但促进再生的因子供应不足,抑制再生的因子供应充足,限制了它们的再生能力。我们的长期目标是开发一种基于生物材料的联合疗法,通过桥接损伤部位来控制微环境,这是通过桥接微观结构和局部基因传递来提供刺激和指导再生的因素来实现的。该建议开发了用于脊髓再生的多通道桥,能够从每个通道中空间控制递送一个或多个神经营养蛋白编码质粒。DNA将被固定在桥的通道内,以转染浸润桥的副细胞,并诱导神经营养因子的表达,从而启动轴突伸长进入和穿过通道。此外,每个通道可以装载不同的神经营养蛋白编码质粒或质粒组合,以定制特定神经束的通道。这一假设基于以下观察:1)DNA递送可以诱导体内持续的、局部的转基因表达,2)神经营养因子递送到损伤部位可以促进轴突伸长形成合成桥,3)细胞移植或渗透泵植入不能提供可控制的神经营养因子浓度来促进再生。脊髓包含多个束,这些束位于特定区域,包含不同的神经元类型。基于这些观察结果,实验的重点是设计有效的基因转移桥梁。这些研究分为3个具体目的:1)研究底物介导的DNA传递到桥的通道,并表征转基因表达(数量,持续时间)和细胞转染(数量)。2)在体外验证质粒诱导通道内神经营养因子分泌促进通道内特定神经元群体局部存活的假设。3)验证体内通道内神经营养因子的差异表达将促进轴突延伸到特定神经束通道的假设。空间调控基因传递的发展对于再生复杂的组织结构非常重要,例如在脊髓内观察到的组织结构。这些结果将广泛影响组织工程,因为复杂组织结构的再生是一个基本问题。
英文摘要
DESCRIPTION (provided by applicant): Injury to the spinal cord results in paralysis below the level of the injury, which results from neuron and oligodendrocyte cell death, axonal loss, demyelination, and critically, the limited capacity of the spinal cord neurons to regenerate. Although spinal cord neurons have the innate capacity to regenerate, they are limited by an insufficient supply of factors to promote regeneration, and an abundant supply of factors that inhibit regeneration. Our long-term goal is to develop a combination therapy based on biomaterials that bridge the injury site to control the microenvironment, which is achieved through the bridge microstructure and localized gene delivery to provide factors that stimulate and direct regeneration. This proposal develops multiple channel bridges for spinal cord regeneration that are capable of spatially controlled delivery of one or more neurotrophin encoding plasmids from each channel. DNA will be immobilized within the channels of the bridge to transfect accessory cells infiltrating the bridge, and induce the expression of neurotrophic factors that will initiate axonal elongation into and across the channel. Additionally, each channel can be loaded with a different neurotrophin encoding plasmid, or combination of plasmids, to tailor the channel for specific neural tracts. This hypothesis is based on the observations that i) DNA delivery can induce sustained, localized transgene expression in vivo, ii) neurotrophin delivery to the injury site can promote axonal elongation into a synthetic bridge, iii) cell transplantation or osmotic pump implantation does not provide a controllable concentration of neurotrophins for promoting regeneration, and iv) the spinal cord contains multiple tracts that are located at specific regions and contain different neuronal types Based on these observations, the experimental focus is on designing bridges for efficient gene transfer. These studies are subdivided into 3 specific Aims: 1) Investigate substrate-mediated DNA delivery to the channels of the bridge and characterize transgene expression (quantity, duration) and cell transfection (number). 2) Test the hypotheses that plasmids inducing neurotrophin secretion within the channels promotes localized survival of specific neuronal populations within the channel in vitro. 3) Test the hypothesis that differential expression of neurotrophins within the channels in vivo will promote axonal extension into the channels for specific neural tracts. The development of spatially regulated gene delivery will be important for regenerating complex tissue architectures, such as that observed within the spinal cord. These results will broadly impact tissue engineering, as the regeneration of complex tissue architectures is a fundamental issue.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Balancing cell migration with matrix degradation enhances gene delivery to cells cultured three-dimensionally within hydrogels.
平衡细胞迁移与基质降解可增强向水凝胶内三维培养细胞的基因递送。
DOI:
10.1016/j.jconrel.2010.04.032
发表时间:
2010
期刊:
Journal of controlled release : official journal of the Controlled Release Society
影响因子:
--
作者:
[Shepard,JaclynA, Huang,Alyssa, Shikanov,Ariella, Shea,LonnieD]
通讯作者:
Shea,LonnieD
DOI:
10.1002/bit.22311
发表时间:
2009-08-01
期刊:
BIOTECHNOLOGY AND BIOENGINEERING
影响因子:
3.8
作者:
[Houchin-Ray, Tiffany, Zelivyanskaya, Marina, Huang, Alyssa, Shea, Lonnie D.]
通讯作者:
Shea, Lonnie D.
Scaffolds for culture and transplantation of islet organoids
-
批准号:10380872
-
项目类别:
-
资助金额:$55.07万
-
财政年份:2020
-
负责人:Lonnie D Shea
-
依托单位:
Scaffolds for culture and transplantation of islet organoids
-
批准号:10197921
-
项目类别:
-
资助金额:$55.07万
-
财政年份:2020
-
负责人:Lonnie D Shea
-
依托单位:
Scaffolds for culture and transplantation of islet organoids
-
批准号:9887396
-
项目类别:
-
资助金额:$55.07万
-
财政年份:2020
-
负责人:Lonnie D Shea
-
依托单位:
Microporous scaffolds for enhancing efficiency of beta-cell progenitor maturation in vitro and in vivo
-
批准号:9331833
-
项目类别:
-
资助金额:$21.92万
-
财政年份:2017
-
负责人:Lonnie D Shea
-
依托单位:
Integrated Structural BMP2 Carrier Systems for Cervical Spine Fusion
-
批准号:8720503
-
项目类别:
-
资助金额:$58.19万
-
财政年份:2011
-
负责人:Lonnie D Shea
-
依托单位:
Protein-Releasing Microporous Scaffolds for Cell Replacement Therapy
-
批准号:8977538
-
项目类别:
-
资助金额:$0.51万
-
财政年份:2010
-
负责人:Lonnie D Shea
-
依托单位:
Human islet transplantation on microporous scaffolds
-
批准号:7930629
-
项目类别:
-
资助金额:$18.29万
-
财政年份:2009
-
负责人:Lonnie D Shea
-
依托单位:
Human islet transplantation on microporous scaffolds
-
批准号:7789811
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2009
-
负责人:Lonnie D Shea
-
依托单位:
Biotechnology Predoctoral Training Program
-
批准号:7883854
-
项目类别:
-
资助金额:$9.39万
-
财政年份:2009
-
负责人:Lonnie D Shea
-
依托单位:
Transfected cell arrays for cancer research
-
批准号:7192889
-
项目类别:
-
资助金额:$18.21万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
P30A: Biomaterials Core (6 of 10)
-
批准号:7491495
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
Controlled Release Scaffolds for Nerve Regeneration
-
批准号:7196025
-
项目类别:
-
资助金额:$33.79万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
Transfected cell arrays for cancer research
-
批准号:7499610
-
项目类别:
-
资助金额:$14.57万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
P30A: Biomaterials Core (6 of 10)
-
批准号:7921442
-
项目类别:
-
资助金额:$46.0万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
P30A: Biomaterials Core (6 of 10)
-
批准号:8114123
-
项目类别:
-
资助金额:$46.77万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
Biomaterials Core
-
批准号:7467564
-
项目类别:
-
资助金额:$43.28万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
Controlled Release Scaffolds for Nerve Regeneration
-
批准号:7753896
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
Parallel gene delivery from spinal cord bridges
-
批准号:7258135
-
项目类别:
-
资助金额:$20.98万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
P30A: Biomaterials Core (6 of 10)
-
批准号:7645616
-
项目类别:
-
资助金额:$45.25万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
Controlled Release Scaffolds for Nerve Regeneration
-
批准号:7342013
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
海外基金